{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:29Z","timestamp":1789560749815,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["13010604"],"award-info":[{"award-number":["13010604"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100757","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:48:32Z","timestamp":1784836112000},"page":"100757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects"],"prefix":"10.1016","volume":"24","author":[{"given":"Alaaeldin","family":"Fayez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora N.","family":"Esmaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiam Abdel","family":"Raouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad M.","family":"Aboelenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Nour Eldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6265","key":"10.1016\/j.jgeb.2026.100757_bb0005","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.aac9396","article-title":"De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies","volume":"350","author":"Homsy","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100757_bb0010","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100757_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm.2016.94","article-title":"Notch signalling in context","volume":"17","author":"Bray","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK\u2013RAS\u2013RAF signaling pathway in Cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100757_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/jcdd12070266","article-title":"MAPK, PI3K\/Akt pathways, and GSK-3\u03b2 activity in severe acute heart failure in intensive care patients: an updated review","volume":"12","author":"Meco","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100757_bb0030","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.1007\/s11033-022-07468-0","article-title":"Interplay between PI3K\/AKT pathway and heart disorders","volume":"49","author":"Ghafouri-Fard","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jgeb.2026.100757_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.595849","article-title":"Phosphoinositide signaling and mechanotransduction in cardiovascular biology and disease","volume":"8","author":"Krajnik","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100757_bb0040","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the role of the PI3K\/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in Normal and diabetic heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100757_bb0045","first-page":"1244","article-title":"New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects","volume":"18","author":"Fayez","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100757_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/bbrj.bbrj_106_18","article-title":"Using postgenome-wide association study analysis; Vars2-Pic3ca-AKT is novel putative interactive pathway associated with conotruncal heart defects","volume":"2","author":"Fayez","year":"2018","journal-title":"Biomed Biotechnol Res J"},{"issue":"19","key":"10.1016\/j.jgeb.2026.100757_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197320","article-title":"Drug development and the use of induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug toxicity screening","volume":"21","author":"Ovics","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100757_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrd4090","article-title":"Phase II and phase III attrition rates 2011\u20132012","volume":"12","author":"Arrowsmith","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100757_bb0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013\u20132015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jgeb.2026.100757_bb0070","series-title":"The SAGE Encyclopedia of Stem Cell Research","author":"Bouhassira","year":"2015"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0075","first-page":"5","article-title":"Innovative cell culture methods in drug development","volume":"18","author":"Schleger","year":"2001","journal-title":"PubMed"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.ogx.0000305204.97355.0d","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"63","author":"Takahashi","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jgeb.2026.100757_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-025-04360-y","article-title":"Neurodevelopment in congenital heart disease: a review of antenatal mechanisms and therapeutic potentials","author":"Sajid","year":"2025","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100757_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.RES.0000109792.43271.47","article-title":"Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells","volume":"94","author":"Planat-B\u00e9nard","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jgeb.2026.100757_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vascn.2018.01.404","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) to model arrhythmogenic diseases","volume":"93","author":"Pourrier","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100757_bb0100","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/eurheartj\/ehw113","article-title":"Position paper of the European Society of Cardiology Working Group Cellular Biology of the heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure","volume":"37","author":"Madonna","year":"2016","journal-title":"Eur Heart J"},{"issue":"1\u20132","key":"10.1016\/j.jgeb.2026.100757_bb0105","first-page":"277","article-title":"Human serum is a suitable supplement for the osteogenic differentiation of human adipose-derived stem cells seeded on Poly-3-Hydroxibutyrate-co-3-Hydroxyvalerate scaffolds","volume":"19","author":"Cl\u00e1udia","year":"2012","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0110","article-title":"Acquisition of durable insulin-producing cells from human adipose tissue-derived mesenchymal stem cells as a foundation for cell- based therapy of diabetes mellitus","volume":"14","author":"Eldeen","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100757_bb0115","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.scr.2013.05.008","article-title":"Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis","volume":"11","author":"Maumus","year":"2013","journal-title":"Stem Cell Res"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100757_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/bioengineering4020047","article-title":"Hypoxic three-dimensional scaffold-free aggregate cultivation of mesenchymal stem cells in a stirred tank reactor","volume":"4","author":"Egger","year":"2017","journal-title":"Bioengineering"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100757_bb0125","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.3892\/mmr.2017.7333","article-title":"Differentiation of mesenchymal stem cells from human amniotic fluid to cardiomyocyte-like cells","volume":"16","author":"Markmee","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-022-01207-x","article-title":"Drug toxicity assessment: cell proliferation versus cell death","volume":"8","author":"Sazonova","year":"2022","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100757_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100757_bb0140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/17425255.2016.1206887","article-title":"Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease","volume":"12","author":"Bizzarri","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100757_bb0145","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.3390\/ijms23126747","article-title":"The inositol phosphate system\u2014a coordinator of metabolic adaptability","volume":"23","author":"Tu-Sekine","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/biom15030451","article-title":"Inositol and PIP2\/PIP3 ratio: at the crossroad of the biodynamic Interface between cells and their microenvironment","volume":"15","author":"Lentini","year":"2025","journal-title":"Biomolecules"},{"issue":"7112","key":"10.1016\/j.jgeb.2026.100757_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Di Paolo","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100757_bb0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2014.10.011","article-title":"Phosphoinositides in the regulation of actin cortex and cell migration","volume":"1851","author":"Tsujita","year":"2015","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030634","article-title":"Phosphoinositides, major actors in membrane trafficking and lipid signaling pathways","volume":"18","author":"De Craene","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"43","key":"10.1016\/j.jgeb.2026.100757_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1705032114","article-title":"Mechanistic principles underlying regulation of the actin cytoskeleton by phosphoinositides","volume":"114","author":"Senju","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\u20136","key":"10.1016\/j.jgeb.2026.100757_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/10799893.2019.1585452","article-title":"miR-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN\/PI3K\/AKT pathway","volume":"38","author":"Hao","year":"2018","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jgeb.2026.100757_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jbior.2017.09.001","article-title":"Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved","volume":"67","author":"Ramos","year":"2018","journal-title":"Adv Biol Regul"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100757_bb0185","doi-asserted-by":"crossref","first-page":"e3000133","DOI":"10.1371\/journal.pbio.3000133","article-title":"Lens differentiation is controlled by the balance between PDGF and FGF signaling","volume":"17","author":"Li","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgeb.2026.100757_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100693","article-title":"Phosphoinositides in cell proliferation and metabolism","volume":"75","author":"Hirsch","year":"2020","journal-title":"Adv Biol Regul"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molcel.2011.01.030","article-title":"Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110\u03b3","volume":"42","author":"Perino","year":"2011","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.jgeb.2026.100757_bb0205","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jgeb.2026.100757_bb0210","series-title":"Cardiac Vasc Biol","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-031-23965-6_2","article-title":"Mechanotransduction in heart development","author":"Giovou","year":"2023"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100757_bb0215","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/jcm8040520","article-title":"Advanced evolution of pathogenesis concepts in cardiomyopathies","volume":"8","author":"Li","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BCJ20180022","article-title":"Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids","volume":"476","author":"Dickson","year":"2019","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100757_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050655","article-title":"Common variation in cytoskeletal genes is associated with conotruncal heart defects","volume":"12","author":"Musfee","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100757_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-4889(01)00188-4","article-title":"Identification of interaction between MEK2 and A-Raf-1","volume":"1589","author":"Yin","year":"2002","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100757_bb0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/biology10040346","article-title":"ERK1\/2: an integrator of signals that alters cardiac homeostasis and growth","volume":"10","author":"Gilbert","year":"2021","journal-title":"Biology"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100757_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.022352","article-title":"Loss of PI3K\u03b1 mediates protection from myocardial ischemia\u2013reperfusion injury linked to preserved mitochondrial function","volume":"12","author":"Zhabyeyev","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100757_bb0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/cjop.CJOP-D-23-00103","article-title":"Impacts of Delta 9-tetrahydrocannabinol against myocardial ischemia\/reperfusion injury in diabetic rats","volume":"66","author":"Zhao","year":"2023","journal-title":"Chin J Phys"},{"issue":"189","key":"10.1016\/j.jgeb.2026.100757_bb0250","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.24976\/Discov.Med.202436189.191","article-title":"Sevoflurane activates PI3K\/AKT signaling pathway by upregulating GDF11 expression to attenuate ischemia\/reperfusion injury in cardiomyocytes","volume":"36","author":"Zhou","year":"2024","journal-title":"Discov Med"},{"key":"10.1016\/j.jgeb.2026.100757_bb0255","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.2147\/IJN.S512135","article-title":"Lymph node exosomes delivery attenuates myocardial ischemia-reperfusion injury via regulating PTEN-PI3K\/Akt pathway mediated myocardiocyte apoptosis","volume":"20","author":"Qiao","year":"2025","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0260","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2017.03.119","article-title":"Urolithin a alleviates myocardial ischemia\/reperfusion injury via PI3K\/Akt pathway","volume":"486","author":"Tang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100757_bb0265","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2018.02.121","article-title":"Celastrol pretreatment attenuates rat myocardial ischemia\/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K\/Akt pathway","volume":"497","author":"Tong","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jgeb.2026.100757_bb0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.intimp.2019.04.060","article-title":"Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K\/AKT signal pathway","volume":"73","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100757_bb0275","first-page":"6759","article-title":"Association of the PPAR\u03b3\/PI3K\/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic\/reperfusion injury","volume":"17","author":"Li","year":"2018","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100757_bb0280","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/1566524019666191105150709","article-title":"Effects of hydrogen-rich water on the PI3K\/AKT signaling pathway in rats with myocardial ischemia-reperfusion injury","volume":"20","author":"Li","year":"2019","journal-title":"Curr Mol Med"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100757_bb0285","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/jcmm.13107","article-title":"Protective effects of Araloside C against myocardial ischaemia\/reperfusion injury: potential involvement of heat shock protein 90","volume":"21","author":"Wang","year":"2017","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:59:36Z","timestamp":1789559976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001010"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100757","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100757"}}